Skip to content

Newsroom

The Media Call for journalists on Q2 2024 financial results takes place on July 30, 2024

Order our news

Would you like to be included on our distribution list for our news? We would be happy to provide you with our latest press releases and short news by e-mail. This service is free of charge and may be cancelled at any time.

You can cancel this free service at any time by sending an e-mail to ir(at)freseniusmedicalcare.com, or by calling +49 (0) 6172 - 609 2525.

The information you provide will only be used to answer your query. For more information on how we process your Personal Data please read our privacy policy.

newsletter registration

captcha
| Press release
Fresenius Medical Care successfully upsizes and extends accounts receivable facility
Fresenius Medical Care AG & Co. KGaA (“the company” or “Fresenius Medical Care”; Frankfurt Stock Exchange: FME / New York Stock Exchange: FMS), the world’s largest provider of dialysis products and…
| Press release
Fresenius Medical Care Reports Strong Second Quarter and Half Year Results; confirms Outlook for 2011 and plans to acquire Liberty Dialysis as well as American Access Care
Second Quarter 2011 Summary Net revenue   $   3,194 million   +   8% Operating income (EBIT)   $   510 million   +   9% Net…
| Press release
Fresenius Medical Care completes acquisition of Euromedic’s dialysis service business
Fresenius Medical Care AG & Co. KGaA (“the Company” or “Fresenius Medical Care”; Frankfurt Stock Exchange: FME / New York Stock Exchange: FMS), the world’s largest provider of dialysis products and…
| Press release
Fresenius Medical Care anticipates continued strong growth − Shareholders approve 14th consecutive annual dividend increase
Fresenius Medical Care, the world’s largest provider of products and services for individuals undergoing dialysis because of chronic kidney failure, anticipates a substantial increase in revenue and…
| Press release
Fresenius Medical Care Reports Strong Start for 2011 and Raises Guidance for Full Year 2011
First Quarter 2011 Summary: Net revenue $ 3,036 million + 6% Operating income (EBIT) $ 445 million + 5% Net income attributable to Fresenius Medical…
| Press release
Fresenius Medical Care and SEHA conclude agreement to serve dialysis patients in Abu Dhabi
Fresenius Medical Care AG & Co. KGaA (Frankfurt Stock Exchange: FME / New York Stock Exchange: FMS), the world’s largest provider of dialysis products and services, announced an agreement with Abu…
| Press release
Fresenius Medical Care’s Patient Safety Organization Gains Official Certification by U.S. Department of Health and Human Services
Fresenius Medical Care AG & Co. KGaA (“the company” or “Fresenius Medical Care”), the world’s largest provider of dialysis products and services, announced today that the U.S. Agency for Healthcare…
| Press release
Fresenius Medical Care acquires Hema Metrics Crit-Line® system business
Fresenius Medical Care AG & Co. KGaA (“the company” or “Fresenius Medical Care”), the world’s largest provider of dialysis products and services, today announced the acquisition of all assets of Hema…
| Press release
Fresenius Medical Care errichtet zentrales Hochregallager am Standort St. Wendel im Saarland
Fresenius Medical Care, der weltweit führende Anbieter von Produkten und Dienstleistungen für Menschen mit chronischem Nierenversagen, wird ein neues zentrales Hochregallager am Standort St. Wendel im…
| Press release
Fresenius Medical Care Reports Excellent 4th Quarter and Full Year Results; Strong Outlook for 2011
4th Quarter 2010 Summary: Net revenue $ 3,167 million + 4% Operating income (EBIT) $ 539 million + 10% Net income attributable to Fresenius…
| Press release
Fresenius Medical Care successfully places US$650 million and €300 million 10-year senior notes
Fresenius Medical Care AG & Co. KGaA (“the company” or “Fresenius Medical Care”), the world’s largest provider of dialysis products and services, today announced the pricing of US$-denominated and…
| Press release
Fresenius Medical Care announces the offering of US$500 million and €300 million senior notes for refinancing and acquisition purposes
Fresenius Medical Care AG & Co. KGaA (“the company” or “Fresenius Medical Care”), the world’s largest provider of dialysis products and services, today announced its intention to sell US$500 million…
1 ... 23 24 25 ... 26
Related content

Do you have any questions? Contact us!

Fresenius Medical Care is the world’s leading provider of dialysis products and services. Find out more about the company’s key facts and innovations.